BioWorld

April 29, 2008

Targeted Genetics' Gene Therapy Shown to Improve Vision

Data reported from two separate studies showed that gene therapy improved the vision of some patients with a rare inherited degenerative eye disease that leads to blindness by age 30. (BioWorld Today) Read More

Quaker Aiming to Invest $420M Fund in Mid-Atlantic Companies

Allergy Kinase May Find Second Home in HIV Targeting Programs

Nuon Raises $27M to Move Tranilast Through Phase II

Other News To Note

Clinic Roundup

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Microbiota modulates the antidepressant effects of GLP-1 analogues

BioWorld Science

Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...